Dashboard
Manage Tickers

LLYELI LILLY & Co

NYSE lilly.com


$ 935.91 $ 11.58 (1.25 %)    

Thursday, 12-Sep-2024 15:29:28 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 473.12 $ 4.49 (0.96 %)
DIA $ 411.29 $ 1.83 (0.45 %)
SPY $ 558.76 $ 3.77 (0.68 %)
TLT $ 100.07 $ -0.30 (-0.3 %)
GLD $ 236.05 $ 1.41 (0.6 %)
$ 920.89
$ 924.33
$ 930.00 x 306
$ 960.00 x 106
$ 924.33 - $ 936.80
$ 513.12 - $ 972.53
2,721,114
na
875.24B
$ 0.59
$ 119.21
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-08-2024 06-30-2024 10-Q
2 04-30-2024 03-31-2024 10-Q
3 02-21-2024 12-31-2023 10-K
4 11-02-2023 09-30-2023 10-Q
5 08-08-2023 06-30-2023 10-Q
6 04-27-2023 03-31-2023 10-Q
7 02-22-2023 12-31-2022 10-K
8 11-01-2022 09-30-2022 10-Q
9 08-04-2022 06-30-2022 10-Q
10 04-29-2022 03-31-2022 10-Q
11 02-23-2022 12-31-2021 10-K
12 10-27-2021 09-30-2021 10-Q
13 08-03-2021 06-30-2021 10-Q
14 04-30-2021 03-31-2021 10-Q
15 02-17-2021 12-31-2020 10-K
16 10-28-2020 09-30-2020 10-Q
17 07-31-2020 06-30-2020 10-Q
18 05-01-2020 03-31-2020 10-Q
19 02-19-2020 12-31-2019 10-K
20 10-25-2019 09-30-2019 10-Q
21 08-02-2019 06-30-2019 10-Q
22 05-02-2019 03-31-2019 10-Q
23 02-19-2019 12-31-2018 10-K
24 11-06-2018 09-30-2018 10-Q
25 07-25-2018 06-30-2018 10-Q
26 04-27-2018 03-31-2018 10-Q
27 02-20-2018 12-31-2017 10-K
28 10-27-2017 09-30-2017 10-Q
29 07-28-2017 06-30-2017 10-Q
30 05-01-2017 03-31-2017 10-Q
31 02-21-2017 12-31-2016 10-K
32 10-28-2016 09-30-2016 10-Q
33 07-28-2016 06-30-2016 10-Q
34 04-29-2016 03-31-2016 10-Q
35 02-19-2016 12-31-2015 10-K
36 10-30-2015 09-30-2015 10-Q
37 07-30-2015 06-30-2015 10-Q
38 04-30-2015 03-31-2015 10-Q
39 02-19-2015 12-31-2014 10-K
40 10-29-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

eli-lilly-pumps-800m-into-irish-operations-to-meet-skyrocketing-demand-for-mounjaro-zepbound
Eli Lilly Pumps $800M Into Irish Operation...
09/12/2024 14:05:57

The investment is aimed at ensuring a steady supply of the drugs, which have been grappling with shortages since 2022.

unpacking-the-latest-options-trading-trends-in-eli-lilly
Unpacking the Latest Options Trading Trend...
09/12/2024 14:03:16

eli-lilly-boosts-manufacturing-investment-in-limerick-ireland-by-1b-unveils-new-800m-kinsale-facility
Eli Lilly Boosts Manufacturing Investment ...
09/12/2024 09:31:47

This additional investment is part of the most ambitious manufacturing expansion agenda in the company's history. Since 202...

Core News & Articles
Roche Says In CT-996 Phase 1 Trial, 4-Week...
09/11/2024 15:49:52

- Reuters

could-elon-musk-become-the-worlds-first-trillionaire-teslas-success-could-make-it-happen-as-early-as
Could Elon Musk Become The World's First T...
09/11/2024 13:32:04

A new study predicts Elon Musk will become the world's first trillionaire if Tesla can regain the $1 trillion market cap le...

ozempic-maker-novo-nordisk-touts-encouraging-data-from-new-obesity-pill-showing-double-weight-loss-compared-to-wegovy
Ozempic Maker Novo Nordisk Touts Encouragi...
09/11/2024 13:13:52

Novo Nordisk presented data on its next-generation weight-loss candidate, amycretin, which showed a significant 13% weight loss...

novo-nordisk-reports-positive-results-of-weight-loss-drug-liraglutide-for-children-as-young-as-6-eyes-fda-and-ema-approval
Novo Nordisk Reports Positive Results Of W...
09/11/2024 08:19:30

Novo Nordisk has announced that its weight-loss drug liraglutide is safe and effective for children as young as six. The compan...

heres-how-much-you-would-have-made-owning-eli-lilly-stock-in-the-last-20-years
Here's How Much You Would Have Made Owning...
09/10/2024 20:00:20

eli-lillys-once-weekly-insulin-efsitora-alfa-achieves-comparable-a1c-reduction-to-daily-insulin-degludec-in-phase-3-qwint-2-trial-results-published-in-nejm-and-presented-at-easd-2024-efsitora-reduced-a1c-by-134-compared-to-126-for-insulin-degludec
Eli Lilly's Once-Weekly Insulin Efsitora A...
09/10/2024 15:27:54

In QWINT-2, efsitora helped adults naïve to insulin therapy currently using and not using GLP-1 receptor agonists achieve an A1...

zepbound-and-mounjaro-maker-eli-illy-has-a-new-cfo-as-it-navigates-regulatory-challenges-what-you-should-know
Zepbound And Mounjaro Maker Eli Illy Has A...
09/10/2024 03:00:59

Eli Lilly and Company has appointed Lucas Montarce as executive vice president and chief financial officer, effective immediate...

a-glimpse-into-the-expert-outlook-on-eli-lilly-through-28-analysts
A Glimpse Into The Expert Outlook On Eli L...
09/09/2024 20:00:18

cantor-fitzgerald-reiterates-overweight-on-eli-lilly-maintains-885-price-target
Cantor Fitzgerald Reiterates Overweight on...
09/09/2024 15:47:21

Cantor Fitzgerald analyst Louise Chen reiterates Eli Lilly (NYSE:LLY) with a Overweight and maintains $885 price target.

smart-money-is-betting-big-in-lly-options
Smart Money Is Betting Big In LLY Options
09/09/2024 14:15:56

eli-lilly-appoints-lucas-montarce-as-executive-vice-president-and-cfo-effective-immediately
Eli Lilly Appoints Lucas Montarce As Execu...
09/09/2024 10:46:23

innovent-bio-hopes-for-plus-sized-profits-from-obesity-drug
Innovent Bio hopes for plus-sized profits ...
09/06/2024 19:16:41

Key Takeaways: Sales approval for the company’s anti-obesity drug mazdutide may drag out beyond this year, potentially allow...

fda-battles-backlog-of-drug-factory-inspections-since-covid-19
FDA Battles Backlog of Drug Factory Inspec...
09/06/2024 15:52:51

FDA faces inspection backlog with serious public health implications, as critical drug manufacturing plants remain unchecked.

stock-of-the-day-heres-why-weight-loss-drug-maker-eli-lilly-has-reversed
Stock Of The Day: Here's Why Weight-Loss D...
09/06/2024 15:25:39

Shares of Eli Lilly hit resistance at the $955 level. Now they are heading lower. These moves are due to investor psychology.

comparative-study-eli-lilly-and-industry-competitors-in-pharmaceuticals-industry
Comparative Study: Eli Lilly And Industry ...
09/06/2024 15:00:14

fake-ozempic-targets-weight-loss-market-forged-batches-an-international-concern
Fake Ozempic Targets Weight-Loss Market: F...
09/05/2024 17:17:20

Criminals distribute fake Ozempic by forging batch numbers. Novo Nordisk suspects one source in global counterfeiting operation...

battle-over-compounded-weight-loss-medications---sustainability-and-regulation
Battle Over Compounded Weight-Loss Medicat...
09/05/2024 16:47:47

Explore how Hims & Hers competes with big pharma amid weight-loss drug shortages, offering cheaper alternatives and facing ...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION